James Rock
Corporate Officer/Principal presso DERMTECH, INC.
Profilo
James Rock is currently the VP of Clinical Operations & Research Contracts at DermTech Operations, Inc. and DermTech, Inc. He previously worked as the Director of New Product Development at IASO Pharma, Inc., Senior Director of Clinical Affairs at Vital Therapies, Inc., Director of Clinical Development at MPEX Pharmaceuticals, Inc., Manager of Clinical Trial at Santarus, Inc., Principal at Maret Pharmaceuticals, Inc. and SD Pharmaceuticals, Inc., and Vice President of Clinical Affairs at Trinity Biotech, Inc. He holds an MBA from Pepperdine University, a graduate degree from Springfield College, and an undergraduate degree from the University of Vermont.
Posizioni attive di James Rock
Società | Posizione | Inizio |
---|---|---|
DERMTECH, INC. | Corporate Officer/Principal | 03/09/2019 |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Chief Tech/Sci/R&D Officer | - |
Precedenti posizioni note di James Rock
Società | Posizione | Fine |
---|---|---|
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/02/2007 |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/12/2005 |
Trinity Biotech, Inc.
Trinity Biotech, Inc. Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Trinity Biotech, Inc. develops, manufactures and markets diagnostic test kits. The private company is based in Jamestown, NY. The CEO of the company is Ronan O'Caoimh. | Corporate Officer/Principal | - |
IASO PHARMA INC | Chief Executive Officer | - |
SD Pharmaceuticals, Inc.
SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a private company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Corporate Officer/Principal | - |
Formazione di James Rock
Pepperdine University | Masters Business Admin |
Springfield College | Graduate Degree |
University of Vermont | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DERMTECH, INC. | Health Technology |
Aziende private | 8 |
---|---|
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Health Technology |
IASO Pharma, Inc.
IASO Pharma, Inc. Pharmaceuticals: MajorHealth Technology IASO Pharma, Inc. operated as a development stage biopharmaceutical company which focused on acquiring, developing and commercializing drugs for the treatment and prevention of infectious diseases and other serious illnesses. The company was founded on October 5, 2006 and is headquartered in San Diego, CA. | Health Technology |
Maret Pharmaceuticals, Inc.
Maret Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Maret Pharmaceuticals, Inc. develops pharmaceutical products for the treatment of hematology and oncology disorders. The company is based in Newport Beach, CA. Maret Pharmaceuticals was acquired by Essential Therapeutics, Inc. on March 12, 2002 for $6.72 million. | Commercial Services |
Vital Therapies, Inc.
Vital Therapies, Inc. Pharmaceuticals: MajorHealth Technology Vital Therapies, Inc. operates as a biotherapeutic company, which develops a cell-based therapy targeting the treatment of acute forms of liver failure. Its product candidate, ELAD System, is a human cell-based bio-artificial liver support system that operates outside the body or extracorporeal. The company was founded in May 2003 and is headquartered in San Diego, CA. | Health Technology |
DermTech Operations, Inc.
DermTech Operations, Inc. Medical SpecialtiesHealth Technology DermTech Operations, Inc. engages in the provision of molecular dermatology. It develops products that facilitate the early detection of skin cancers, assess inflammatory diseases, and customize drug treatments. The firm's products include adhesive skin collection kit, pigmented lesion assay (PLA), nevome, inflammatory disease and carcinome. The company was founded by Lawrence A. Rheins in 1996 and is headquartered in La Jolla, CA. | Health Technology |
SD Pharmaceuticals, Inc.
SD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Savara, Inc., SD Pharmaceuticals, Inc. is a private company that researches and develops reformulated treatment products for cancer and other infectious diseases. The company is based in Carlsbad, CA. The company was founded by Andrew Xian Chen. SD Pharmaceuticals was acquired by Mast Therapeutics, Inc. on April 28, 2006 for $9.89 million. | Health Technology |
MPEX Pharmaceuticals, Inc.
MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services MPEX Pharmaceuticals, Inc. develops and manufactures therapies for antibiotic resistance with focus on gram-negative organisms. It offers Aeroquin (MP- 376), an aerosol formulation of levofloxacin for the treatment of pulmonary infections in patients with cystic fibrosis, as well as antibiotic programs to address antibiotic resistance in gram negative organisms. The company was founded in 2001 and is headquartered in San Diego, CA. | Commercial Services |
Trinity Biotech, Inc.
Trinity Biotech, Inc. Medical SpecialtiesHealth Technology Part of MiCo IVD Holdings, LLC, Trinity Biotech, Inc. develops, manufactures and markets diagnostic test kits. The private company is based in Jamestown, NY. The CEO of the company is Ronan O'Caoimh. | Health Technology |
- Borsa valori
- Insiders
- James Rock